Biopsy Devices Market Growth Driven by Innovation and Minimally Invasive Diagnostics

The biopsy devices market is witnessing strong growth as healthcare providers increasingly focus on early, precise, and minimally invasive disease diagnosis. Biopsy devices enable clinicians to collect tissue or cellular samples for pathological examination, making them particularly important in cancer diagnosis. According to DelveInsight, the global market was valued at USD 5,813.16 million in 2024 and is anticipated to reach USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% from 2025 to 2032. Increasing cancer prevalence, technological progress, preference for less invasive procedures, and ongoing product development are among the factors supporting market expansion. Interestingly, broader diagnostic markets such as the athletes foot treatment market also demonstrate how advances in specialized healthcare products are expanding opportunities across medical segments.

Biopsy Devices Market: Growing Cancer Incidence Supports Demand

The rising worldwide burden of cancer remains a significant contributor to the adoption of biopsy technologies. Cancers affecting the breast, lungs, prostate, and colon frequently require tissue sampling to confirm malignancy, establish disease characteristics, and guide treatment decisions. DelveInsight estimates that global breast cancer incidence reached approximately 2,296,841 cases in 2022 and may rise to around 3,364,291 cases by 2045. Greater emphasis on screening, early diagnosis, and individualized treatment is therefore increasing the need for dependable tissue acquisition technologies.

Beyond oncology, biopsy procedures are increasingly used to investigate inflammatory, infectious, gastrointestinal, and other medical conditions. As diagnostic pathways become more advanced, physicians are seeking technologies capable of collecting representative samples with reduced discomfort and fewer procedural complications. This expanding clinical application is supporting demand across hospitals, diagnostic laboratories, imaging centers, and ambulatory healthcare facilities.

Biopsy Devices Market: Technology Is Transforming Tissue Sampling

Advances in medical technology are changing the way biopsy procedures are performed by improving targeting accuracy, workflow efficiency, and patient safety. Contemporary biopsy systems increasingly incorporate vacuum-assisted mechanisms, image-guided navigation, robotics, automation, artificial intelligence, and digital pathology. These innovations can help clinicians obtain high-quality samples while limiting unnecessary tissue damage.

The advanced biopsy device solutions are increasingly connected with smart sensors, imaging platforms, automated workflows, and data-assisted decision-making. Robotic technologies can support accurate needle placement, while AI-enabled pathology platforms can assist specialists in evaluating collected specimens. Similar technological innovation can be observed across other specialized healthcare categories, including the tinea pedis treatment market, where product development is also focused on improving convenience and treatment delivery.

Biopsy Devices Market: Breast Applications Remain Important

Breast biopsy continues to represent a major application area because of the substantial global burden of breast cancer and the widespread implementation of screening programs. Mammography and ultrasound can identify suspicious lesions that require tissue confirmation, creating sustained demand for breast biopsy technologies. DelveInsight estimates that breast biopsy represented approximately 30% of the overall market in 2024.

Core needle biopsy, fine-needle aspiration, and vacuum-assisted breast biopsy techniques are increasingly utilized because they can provide diagnostic tissue samples without requiring traditional open surgical procedures in many cases. In May 2024, Hologic introduced a disposable 7-gauge breast biopsy needle for its Brevera breast biopsy system in Europe, supplementing its existing 9-gauge option. Such product developments highlight the industry's focus on improving sample collection, procedural adaptability, and patient experience.

Biopsy Devices Market: Needle-Based Products Maintain Strong Demand

Needle-based biopsy instruments are expected to continue representing a substantial portion of overall product demand. DelveInsight estimates that this segment accounted for nearly 39% of the market in 2024. Core biopsy needles, fine-needle aspiration instruments, and vacuum-assisted biopsy needles are widely adopted because they enable tissue collection through comparatively minimally invasive approaches.